BioMarin Reviews Status of Exon 51 Composition of Matter and Method of Use Patent Interference Cases against Sarepta Therapeutics
Go back to BioMarin Reviews Status of Exon 51 Composition of Matter and Method of Use Patent Interference Cases against Sarepta Therapeutics| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 55.90 +1.21 (2.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.69 | 52 Week High | $108.96 | |||
| Open | $55.51 | 52 Week Low | $62.12 | |||
| Day High | $56.31 | P/E | N/A | |||
| Day Low | $54.96 | EPS | $-1.27 | |||
| Volume | 3,014,555 | |||||
